ORIGINAL RESEARCH article

Front. Microbiol., 16 June 2016

Sec. Antimicrobials, Resistance and Chemotherapy

Volume 7 - 2016 | https://doi.org/10.3389/fmicb.2016.00899

Streptomyces antioxidans sp. nov., a Novel Mangrove Soil Actinobacterium with Antioxidative and Neuroprotective Potentials

  • 1. Novel Bacteria and Drug Discovery Research Group, School of Pharmacy, Monash University Malaysia Bandar Sunway, Malaysia

  • 2. Biomedical Research Laboratory, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia Bandar Sunway, Malaysia

  • 3. Biochemistry Program, Faculty of Science, Institute of Biological Sciences, University of Malaya Kuala Lumpur, Malaysia

  • 4. Division of Genetics and Molecular Biology, Faculty of Science, Institute of Biological Sciences, University of Malaya Kuala Lumpur, Malaysia

  • 5. Center of Health Outcomes Research and Therapeutic Safety (Cohorts), School of Pharmaceutical Sciences, University of Phayao Phayao, Thailand

Abstract

A novel strain, Streptomyces antioxidans MUSC 164T was recovered from mangrove forest soil located at Tanjung Lumpur, Malaysia. The Gram-positive bacterium forms yellowish-white aerial and brilliant greenish yellow substrate mycelium on ISP 2 agar. A polyphasic approach was used to determine the taxonomy status of strain MUSC 164T. The strain showed a spectrum of phylogenetic and chemotaxonomic properties consistent with those of the members of the genus Streptomyces. The cell wall peptidoglycan was determined to contain LL-diaminopimelic acid. The predominant menaquinones were identified as MK-9(H6) and MK-9(H8), while the identified polar lipids consisted of aminolipid, diphosphatidylglycerol, glycolipid, hydroxyphosphatidylethanolamine, phospholipid, phosphatidylinositol, phosphatidylethanolamine, phosphatidylglycerol and lipid. The cell wall sugars consist of galactose, glucose and ribose. The predominant cellular fatty acids (>10.0%) were identified as iso-C15:0 (34.8%) and anteiso-C15:0(14.0%). Phylogenetic analysis identified that closely related strains for MUSC 164T as Streptomyces javensis NBRC 100777T (99.6% sequence similarity), Streptomyces yogyakartensis NBRC 100779T (99.6%) and Streptomyces violaceusniger NBRC 13459T (99.6%). The DNA–DNA relatedness values between MUSC 164T and closely related type strains ranged from 23.8 ± 0.3% to 53.1 ± 4.3%. BOX-PCR fingerprints comparison showed that MUSC 164T exhibits a unique DNA profile, with DNA G + C content determined to be 71.6 mol%. Based on the polyphasic study of MUSC 164T, it is concluded that this strain represents a novel species, for which the name Streptomyces antioxidans sp. nov. is proposed. The type strain is MUSC 164T (=DSM 101523T = MCCC 1K01590T). The extract of MUSC 164T showed potent antioxidative and neuroprotective activities against hydrogen peroxide. The chemical analysis of the extract revealed that the strain produces pyrazines and phenolic-related compounds that could explain for the observed bioactivities.

Introduction

Many therapeutic agents, such as antibiotics, anti-inflammatory and antioxidant compounds have been isolated from microorganisms (Bérdy, 2005; Williams, 2009). Discovery of these bacterial-derived bioactive compounds has a major impact on human health, helping people to live longer and reducing the mortality rate due to infectious and/or chronic diseases. In recent years, the accumulation of free radicals or oxidative stress has been identified as one of the major contribution to neuronal loss and occur early in all major neurodegenerative diseases (Lin and Beal, 2006; Fischer and Maier, 2015; Leszek et al., 2016). By reducing the presence of free radicals, increased intake of antioxidants is known to prevent and decrease the risk of these chronic diseases (Devasagayam et al., 2004; Bonda et al., 2010). Thus, continuous efforts have been directed toward searching for potent, natural antioxidants to prevent the deleterious effects of free radicals.

Over the years, exploring new taxa remains as one of the successful strategies which lead to discovery of therapeutic agents (Williams, 2009). As the most prolific producer of bioactive compounds, Streptomyces genus was initially proposed by Waksman and Henrici (1943) and metabolites isolated from these organisms have been shown to possess pharmaceutically relevant activities such as anti-inflammatory, antimicrobial, antioxidant activities (Bérdy, 2005; Wang et al., 2013; Kumar et al., 2014; Ser et al., 2015a, 2016a; Tan et al., 2016). Moreover, the metabolites derived from Streptomyces are described as potent protective agents in neuronal cells against oxidative stress induced damage. In fact, a recent study by Leiros et al. (2013) has identified seven bioactive compounds produced by Streptomyces sp. which protects against hydrogen peroxide (H2O2) challenge in primary cortical neurons. Unfortunately, many previous drug screening program focused on novel actinomycetes from terrestrial source, which in turn resulted in inefficient rediscovery of known bioactive compounds. Thus, researchers began to divert their attention to new or underexplored habitats, in hope to find new species that may yield promising bioactive compounds.

As one of the world's most dynamic environments, the mangrove ecosystem yields commercial forest products, supports coastal fisheries and protects coastlines (Alongi, 2008). Recently, there has been a renewed interest in the mangrove microorganisms' resources, considering that the changes in salinity and tidal gradient in the mangrove can trigger metabolic adaptations that could result in valuable metabolites production (Hong et al., 2009; Lee et al., 2014a; Azman et al., 2015). Several studies have discovered novel actinobacteria from the poorly explored mangrove environments, demonstrated by the isolation of Streptomyces xiamenensis (Xu et al., 2009), Streptomyces sanyensis (Sui et al., 2011), Streptomyces qinglanensis (Hu et al., 2012), Streptomyces pluripotens (Lee et al., 2014b), Streptomyces gilvigriseus (Ser et al., 2015b), and Streptomyces mangrovisoli (Ser et al., 2015a). Some of these novel strains are known to be bioactive strains as they were found to produce potent compounds with antibacterial, antifibrotic and antioxidant activities. Overall, these findings emphasized that these mangrove-derived Gram-positive filamentous bacteria could be potentially useful for discovery of new drugs or drug leads for neurodegenerative diseases which role of oxidative stress has been implicated, including Parkinson's diseases, Alzheimer's disease and multiple sclerosis.

In this study, a novel strain, MUSC 164T was discovered from a mangrove soil located in east coast of Peninsular Malaysia. A polyphasic approach determined that MUSC 164T represents a novel species of the Streptomyces genus, for which the name Streptomyces antioxidans sp. nov. is proposed. As a means to explore the bioactivities possessed by the strain, the extract of MUSC 164T was subjected to several antioxidant assays prior to in vitro neuroprotective screening against hydrogen peroxide (H2O2). Gas chromatography-mass spectrometry (GC-MS) was used to perform chemical analysis for MUSC 164T extract in order to reveal the chemical constituents present in the extract. Taken altogether, this study has implicated the potential of the mangrove-derived strain Streptomyces antioxidans sp. nov. in producing bioactive compounds, specifically with antioxidative and neuroprotective activities.

Materials and methods

Isolation and maintenance of isolate

Strain MUSC 164T was recovered from a soil sample collected at site MUSC-TLS4 (3° 48′ 21.3″ N 103° 20′ 3.3″ E), located in the mangrove forest of Tanjung Lumpur in the state of Pahang, Peninsular Malaysia in December 2012. Topsoil samples of the upper 20 cm layer (after removing the top 2–3 cm) were collected and sampled into sterile plastic bags using an aseptic metal trowel, and stored at −20°C. Air-dried soil samples were ground with a mortar and pestle. Selective pretreatment of soil samples was performed using wet heat in sterilized water (15 min at 50°C; Takahashi et al., 1996). Five grams of the pretreated air-dried soil was mixed with 45 mL sterilized water and mill ground, spread onto the isolation medium ISP 2 (Shirling and Gottlieb, 1966) supplemented with cycloheximide (25 μg/mL) and nystatin (10 μg/mL), and incubated at 28°C for 14 days. Pure cultures of strain MUSC 164T were isolated and maintained on slants of ISP 2 agar and in glycerol suspensions (20% v/v).

Genomic and phylogenetic analyses

Extraction of DNA was performed as previously described (Hong et al., 2009), followed by 16S rRNA gene amplification carried out as stated by Lee et al. (2014b). Using CLUSTAL-X software, the 16S rRNA gene sequence of strain MUSC 164T was aligned with representative sequences of related type strains of the genus Streptomyces retrieved from the GenBank/EMBL/DDBJ databases (Thompson et al., 1997). Subsequently, the alignment was verified manually and adjusted before constructing the phylogenetic trees with the neighbor-joining (Saitou and Nei, 1987; Figure 1) and maximum-likelihood algorithms (Felsenstein, 1981; Figure S1), using the MEGA version 6.0 (Tamura et al., 2013). Evolutionary distances for the neighbor-joining algorithm were computed using Kimura's two-parameter model (Kimura, 1980). Calculations of sequence similarity was performed using EzTaxon-e server (http://eztaxon-e.ezbiocloud.net/) (Kim et al., 2012). The stability of the resultant trees topologies were evaluated by using the bootstrap resampling method of Felsenstein (1985).

Figure 1

BOX-PCR fingerprint analysis was carried out to characterize strain MUSC 164T and the closely related strains using the primer BOX-A1R (5′-CTACGGCAAGGCGACGCTGACG-3′; Versalovic et al., 1991; Lee et al., 2014c). The PCR condition for BOX-PCR was performed as described by Lee et al. (2014d) and the PCR products were visualized by 2% agarose gel electrophoresis.

Genomic DNA extractions for DNA-DNA hybridization of strain MUSC 164T, Streptomyces javensis NBRC 100777T, Streptomyces violaceusniger NBRC 100779T and Streptomyces yogyakartensis NBRC 13459T were performed by the Identification Service of the DSMZ, Braunschweig, Germany following the protocol of Cashion et al. (1977). DNA-DNA hybridization was conducted as described by De Ley et al. (1970) with slight modifications described by Huss et al. (1983). The G + C content of strain MUSC 164T was determined by HPLC (Mesbah et al., 1989).

Chemotaxonomic characteristics

The analyses of peptidoglycan amino acid composition and sugars of strain MUSC 164T were conducted by the Identification Service of the DSMZ using published protocols (Schumann, 2011). Analysis of respiratory quinones, polar lipids (Kates, 1986) and fatty acids (Sasser, 1990) were carried out by the Identification Service of the DSMZ. Major diagnostic cell wall sugars of strain MUSC 164T were obtained as described by Whiton et al. (1985) and analyzed by TLC on cellulose plates (Staneck and Roberts, 1974).

Phenotypic characteristics

The cultural characteristics of strain MUSC 164T were determined following growth on ISP 2, ISP 3, ISP 4, ISP 5, ISP 6, and ISP 7 agar (Shirling and Gottlieb, 1966), actinomycetes isolation agar (AIA; Atlas, 1993), Streptomyces agar (SA; Atlas, 1993), starch casein agar (SCA; Küster and Williams, 1964) and nutrient agar (Macfaddin, 2000) for 14 days at 28°C. The colony color was examined by using the ISCC-NBS color charts (Kelly, 1964). Light microscopy (80i, Nikon) and scanning electron microscopy (JEOL-JSM 6400) were utilized to evaluate the morphology of the strain after incubation on ISP 2 medium at 28°C for 7–14 days (Figure 2). Gram staining was performed and confirmed by using KOH lysis (Cerny, 1978). The growth temperature range was tested at 12–48°C (at intervals of 4°C) on ISP 2 agar, while the pH range for growth was tested in tryptic soy broth (TSB) between pH 4.0–10.0 (at intervals of 1.0 pH unit). Tolerance of NaCl was tested in TSB with concentrations ranging from 0 to 18% (w/v) at intervals of 2%. The responses to temperature, pH and NaCl were observed for 14 days. Catalase activity and production of melanoid pigments were determined following protocols described by Lee et al. (2014e). Hemolytic activity was examined after incubation at 32°C for 7–14 days using blood agar medium containing 5% (w/v) peptone, 3% (w/v) yeast extract, 5% (w/v) NaCl, and 5% (v/v) horse blood (Carrillo et al., 1996). Amylolytic, cellulase, chitinase, lipase, protease, and xylanase activities were determined by growing cells on ISP 2 medium as described by Meena et al. (2013). The carbon-source utilization and chemical sensitivity assays were determined using Biolog GenIII MicroPlates (Biolog, USA) according to the manufacturer's instructions.

Figure 2

All of the phenotypic assays mentioned were performed concurrently for strain MUSC 164T, Streptomyces javensis NBRC 100777T, Streptomyces violaceusniger NBRC 100779T and Streptomyces yogyakartensis NBRC 13459T.

Extract preparation of MUSC 164T

Seed medium was prepared by cultivating strain MUSC 164T in TSB for 14 days prior to fermentation process. Fermentation was conducted in 500 mL Erlenmeyer flask containing 200 mL of sterile FM 3 medium, shaking at 200 rpm for 7–10 days at 28°C (Hong et al., 2009; Lee et al., 2012). The cell mass was separated by centrifugation at 12000 × g for 15 min and the supernatant was filtered and freeze-dried. The freeze-dried sample was extracted repeatedly with methanol. Subsequently, the extracting solvent was removed and concentrated by rotary vacuum evaporator at 40°C. The extract of MUSC 164T was retrieved and suspended in dimethyl sulphoxide (DMSO) as vehicle reagent prior to bioactivity screening assays.

Determination of antioxidant activity of MUSC 164T extract

2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging activity by MUSC 164T extract was determined using previous protocol with minor modification (Ser et al., 2015a). The reduction in radical is measured as decrease in the absorbance of 515 nm. Volume of 195 μL of 0.016% DPPH ethanolic solution was added to 5 μL of extract solution to make up final volume of 200 μL. Gallic acid was included as positive control. Reactions were carried out at room temperature in dark for 20 min before measurement with spectrophotometer at 515 nm. DPPH scavenging activity was calculated as follows:

SOD activity was determined using SOD assay Kit − WST (Sigma-Aldrich) following manufacturer's instructions (Tan et al., 2015). Twenty microliter of sample solution was added to sample and blank 2 wells, while 20 μL of ddH2O was added to blank 1 and blank 3 wells. Subsequently, WST working solution (20 μL) was then added to each well followed by 20 μL of enzyme working solution to the sample and blank 1 wells. The resultant mixtures were mixed thoroughly and incubated at 37°C for 20 min. The absorbance was read at 450 nm and superoxide anion scavenging activity was calculated as follows:

2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) assay was performed as previously described in published literature with some modifications (Miser-Salihoglu et al., 2013; Ser et al., 2016b). ABTS radical cation (ABTS•) was generated by reacting ABTS stock solution (7 mM) and potassium persulphate (2.45 mM) for 24 h prior to assay. The change in radical amount was indicated by decrease in absorbance at 743 nm. Metal-chelating activity was measured as described by Manivasagan et al. (2013) with slight modification. 2 mM of FeSO4was added to extract and the reaction was initiated by adding 5 mM of ferrozine before measuring at 562 nm using spectrophotometer.

Cell lines maintenance and growth condition

Neuronal SH-SY5Y cells were maintained in DMEM media (supplemented with 10% FBS) in humidified incubator (5% CO2 in air at 37°C) as described by Wong et al. (2012) with minor modification.

Assessment of toxicity and neuroprotective activity of MUSC 164T extract

Confluence cells were harvested and seeded at a density of 3 × 104 cells/well into a sterile flat bottom 96-well plate. The seeded cells were allowed to adhere for 48 h before the experiment. Firstly, toxicity of the extract was investigated by treating the cells MUSC 164T extract (0–400 μg/mL) for 24 h prior to measurement of cell viability using MTT assay (Chan et al., 2012). On the other hand, for evaluation of neuroprotective activity, cells were pretreated with MUSC 164T (0–400 μg/mL) extract for 2 h prior to treatment with H2O2 (Wong et al., 2012). For these screenings, media with DMSO was included as negative control along with a non-inoculated extract. Subsequently, MTT assay was performed 24 h after H2O2 treatment. Tetrazolium salt solution was added into each well and incubated further for 4 h. Plates were analyzed in microplate reader at 570 nm (with a reference wavelength of 650 nm). The percentage of cell viability was calculated as follows:

Gas chromatography-mass spectrometry (GC-MS) analysis

GC-MS analysis was performed in accordance with our previous developed method with slight modification (Supriady et al., 2015; Ser et al., 2015a). The machine used was Agilent Technologies 6980N (GC) equipped with 5979 Mass Selective Detector (MS), HP-5MS (5% phenyl methyl siloxane) capillary column of dimensions 30.0 m × 250 × 0.25 μm and used helium as carrier gas at 1 mL/min. The column temperature was programmed initially at 40°C for 10 min, followed by an increase of 3°C/min to 250°C and was kept isothermally for 5 min. The MS was operating at 70 eV. The constituents were identified by comparison of their mass spectral data with those from NIST 05 Spectral Library.

Statistical analysis

Experiments to evaluate bioactivities were performed in quadruplicate and all results were expressed as mean ± standard deviation (SD). Statistical analysis was performed using one-way analysis of variance (ANOVA) with SPSS statistical analysis software. A difference was considered statistically significant when p ≤ 0.05.

Results and discussion

Biologically active compounds isolated from microorganisms remain to be vital for development of new drugs, particularly pharmaceutical and agricultural industry (Bérdy, 2005; Jensen et al., 2005). Oxidative stress has been implicated in pathogenesis of various chronic human disease, particularly neurodegenerative diseases (Radi et al., 2014). An imbalance in free radicals production and antioxidant mechanisms causes modifications and damages on biological macromolecules including protein, lipid and DNA. These detrimental effects of free radicals eventually lead to neuronal cell loss–a scenario which is commonly seen in neurodegenerative diseases (Uttara et al., 2009). Antioxidants are responsible of removing or reducing amount of these harmful radicals; high intake of antioxidants have been associated with reduced risk of developing neurodegenerative diseases (Bonda et al., 2010; Lassmann and van Horssen, 2015). The need to search for novel, potent antioxidative agents to combat against these diseases has called upon researchers to venture into new or underexplored habitats for the discovery of bioactive strains that could produce potent antioxidant(s) (Harvey, 2000; Penesyan et al., 2010). In current study, the mangrove forest soil-derived MUSC 164T strain shows abundant growth on ISP 2, ISP 3, ISP 5, ISP 6, ISP 7 agar, actinomycetes isolation agar, nutrient agar and starch casein agar after 7–14 days at 28°C. The strain grows moderately on Streptomyces agar, and does not grow on ISP 4 agar. The colors of the aerial and substrate mycelium were media-dependent as indicated by Table S1. Both aerial and vegetative hyphae were abundant, well developed and not fragmented as observed observed from 14-day-old culture grown on ISP 2 agar. These morphological features are consistent with assignment of the strain to the genus Streptomyces (Williams et al., 1989). Growth was found to occur at 26–36°C (optimum 28–32°C), with 0–6% NaCl tolerance (optimum 0–2%) and at pH 6.0–8.0 (optimum pH 7.0). Cells were found to be positive for catalase but lack of hemolytic activity and melanoid pigment production. Furthermore, cells were capable of hydrolyzing soluble starch and carboxymethylcellulose, but unable to hydrolyze casein, chitin, tributyrin (lipase) and xylan. Using a range of phenotypic properties, strain MUSC 164T can be differentiated from closely related members of the genus Streptomyces (Table 1). Furthermore, chemical sensitivity assays showed that the strain was resistant to aztreonam, fusidic acid, guanine HCl, lincomycin, lithium chloride, minocycline, nalidixic acid, niaproof 4, potassium tellurite, rifamycin RV, sodium bromate, sodium butyrate, 1% sodium lactate, tetrazolium blue, tetrazolium violet, troleandomycin, and vancomycin.

Table 1

Characteristic1234
MORPHOLOGY (ON ISP 2):
Color of aerial myceliumYellowish whiteYellowish whitePale orange yellowVivid greenish yellow
Color of substrate myceliumBrilliant greenish yellowLight yellowBrilliant yellowBrilliant Greenish yellow
GROWTH AT:
26°C+++(+)
36°C(+)++−
pH 8(+)−−+
4% NaCl(+)++−
Catalase++++
Hemolytic−−−−
HYDROLYSIS OF:
Casein (protease)−+−+
Tributyrin (lipase)−+++
Starch (amylolytic)++++
Carboxymethylcellulose (cellulase)++++
Xylan (xylanase)−+++
CARBON SOURCE UTILIZATION:
Dextrin−+++
Gentiobiose−−++
Sucrose+−−−
D−turanose+−−−
Stachyose+−−−
α−D−lactose−+++
D−melibiose−−++
N−acetyl−neuraminic acid+−−−
D−mannose−−++
D−fructose−−++
D−galactose−−+−
L−fucose−+++
Inosine−−++
D−mannitol−+++
p−hydroxy−phenylacetic acid+−−−
acetoacetic acid+−−−
CHEMICAL SENSITIVITY ASSAYS:
Troleandomycin+−−−
Vancomycin+−−−
Fusidic acid+−−−
Lincomycin+−−−
Niaproof 4+−−−
Lithium chloride+−−−
Guanidine HCl+−−−

Differentiation characteristics of strain MUSC 164T and type strains of phylogenetically closely related species of the genus Streptomyces.

Strains: 1, Streptomyces antioxidans sp. nov. MUSC 164T; 2, Streptomyces javensis NBRC 100777T; 3, Streptomyces yogyakartensis NBRC 100779T; 4, Streptomyces violaceusniger NBRC 13459T. All data were obtained concurrently in this study. +, Positive; −, negative; (+), weak.

All strains are positive for utilization of D-cellobiose, D-raffinose, N-acetyl-D-glucosamine, α-D-glucose, gelatin, glucuronamide, γ-amino-butyric acid, α-hydroxy-butyric acid, β-hydroxy-D,L-butyric acid, and α-keto-butyric acid. All strains are negative for assimilation of D-maltose, β -methyl-D-glucoside, D-salicin, N-acetyl- β -D-mannosamine, N-acetyl-D-galactosamine, 3-methyl glucose, D-fucose, D-sorbitol, D-glucose-6-PO4, D-serine and citric acid.

The nearly complete 16S rRNA gene sequence was obtained for strain MUSC 164T (1491 bp; GenBank/EMBL/DDBJ accession number KJ632665) and phylogenetic trees were reconstructed to determine the phylogenetic position of this strain (Figure 1, Figure S1). Phylogenetic analysis exhibited that closely related strains include Streptomyces javensis NBRC 100777T, Streptomyces yogyakartensis NBRC 100779T and Streptomyces violaceusniger NBRC 13459T, as they formed a distinct clade at high bootstrap value of 81% (Figure 1). The analysis of 16S rRNA gene sequence for strain MUSC 164T exhibited highest similarity to strain Streptomyces javensis NBRC 100777T (99.6% sequence similarity), Streptomyces yogyakartensis NBRC 100779T (99.6%) and Streptomyces violaceusniger NBRC 13459T (99.6%); while the type strains of other species of the genus Streptomyces showed sequences similarities below 99.3%. The DNA–DNA relatedness values between strain MUSC 164T and Streptomyces javensis NBRC 100777T (23.8 ± 0.2%), Streptomyces yogyakartensis NBRC 100779T (30.2 ± 2.7%) and Streptomyces violaceusniger NBRC 13459T (53.1 ± 4.4%) were significantly below 70% which was reported as the threshold value for the delineation of bacterial species (Wayne et al., 1987). The BOX-PCR analysis revealed a unique fingerprint pattern by strain MUSC 164T as compared with its closely related type strains (Figure S2). These results further supported the results of DNA-DNA hybridizations and phylogenetic analysis, which indicated the novel status of strain MUSC 164T in the genus Streptomyces.

The major cellular fatty acids in MUSC 164T were identified as iso-C15:0 (34.8%) and anteiso-C15:0 (14.0%) (Table 2). The fatty acids profile of MUSC 164T displayed some levels of similarities with those of closely related phylogenetic neighbors such as Streptomyces javensis NBRC 100777T, Streptomyces yogyakartensis NBRC 100779T and Streptomyces violaceusniger NBRC 13459T, as they contain iso-C15:0 (24.1–36.3%) as their predominant fatty acids. Nonetheless, the fatty acid profile of MUSC 164T was quantitatively different from those of these type strains; for instance, iso-C15:0(34.8%) was found to be predominant in strain MUSC 164T (Table 2), but the amount of the same fatty acid was much lesser in Streptomyces yogyakartensis NBRC 100779T (24.1%). The polar lipids of MUSC 164T were aminolipid, diphosphatidylglycerol, glycolipid, hydroxyphosphatidylethanolamine, phospholipid, phosphatidylinositol, phosphatidylethanolamine, phosphatidylglycerol and lipid. The differences in polar lipid profiles indicated that MUSC 164T differs from related type strains; for example, strain MUSC 164T contain aminolipid and glycolipid (Figure S3A) that were not detected in Streptomyces javensis NBRC 100777T (Figure S3B).

Table 2

Fatty acid1234
iso-C11:0−0.1−−
C12:00.10.1−−
iso-C13:01.51.00.50.5
anteiso-C13:00.20.1−0.1
C13:00.1−−−
iso-C14:02.51.73.13.8
C14:00.60.40.30.3
iso-C15:034.836.324.132.5
anteiso-C15:014.010.15.56.9
C15:1B1.20.10.60.2
C15:03.70.71.40.7
iso-C16:1 H0.91.13.52.2
iso-C16:07.09.121.315.1
C16:1 Cis 96.43.74.33.8
anteiso-C15:0 2OH0.3−−−
C16:05.95.44.44.4
iso-C15:0 3OH0.1−−−
C16:0 9Methyl5.39.110.410.0
anteiso-C17:1C1.11.21.21.1
iso-C17:07.613.910.113.8
anteiso-C17:03.94.83.13.3
C17:1Cis 91.10.31.40.2
C17:0Cyclo0.70.21.10.4
C17:00.80.30.50.1
C17:010Methyl−−1.00.1
iso-C18:1H−0.11.30.2
iso-C18:0−0.10.30.2
iso-C17:0 2OH−−0.1−
C18:0−0.10.10.2
iso-C19:0−−−0.1

Cellular fatty acid composition of strain MUSC 164T and its closely related Streptomyces species.

Strains: 1, Streptomyces antioxidans sp. nov. MUSC 164T; 2, Streptomyces javensis NBRC 100777T; 3, Streptomyces yogyakartensis NBRC 100779T; 4, Streptomyces violaceusniger NBRC 13459T. −, < 0.1% or not detected. All data are obtained concurrently from this study.

Strain MUSC 164T presented a type I cell-wall as it contains LL-diaminopimelic acid (Lechevalier and Lechevalier, 1970), an amino acid which has been found in many species of the genus Streptomyces (Lee et al., 2005, 2014b; Xu et al., 2009; Hu et al., 2012; Ser et al., 2015a, Ser et al., 2015b). The predominant menaquinones of strain MUSC 164T were detected as MK-9(H6) (51%) and MK-9(H8) (39%). These findings parallel those reported by Kim et al. (2003). The cell wall sugars detected were galactose, glucose and ribose. The G + C content of strain MUSC 164T was 71.6 mol% which falls within the range of 67.0–78.0 mol% described for species of the genus Streptomyces (Kim et al., 2003).

Based on the results of phylogenetic analysis, DNA-DNA hybridization, chemotaxonomic and phenotypic analysis, it is evident that strain MUSC 164T is different from all other species in the genus Streptomyces; the strain represents a novel species within the genus Streptomyces, for which the name Streptomyces antioxidans sp. nov. is proposed. As an attempt to explore bioactivities possessed by the strain, MUSC 164T extract was subjected to several antioxidant assays. DPPH assay revealed the ability of MUSC 164T to produce free radical scavenging compound(s) as 2 mg/mL of extract showed significant activity at 18.31 ± 2.03% (Table 3). Similarly, the extract was able to reduce ABTS radical and chelate ferrous ion significantly with highest activity recorded to be 30.38 ± 2.27 and 43.66 ± 0.98%, respectively. Additionally, SOD assay suggested antioxidant(s) in MUSC 164T extract with ranging antioxidant activity of 53.09–79.84%, depending on extract concentration. In summary, all the antioxidant assays suggested the potential of MUSC 164T to produce potent antioxidant(s) that could scavenge free radicals and may reduce occurrence of oxidative stress.

Table 3

Antioxidant assaysConcentration of MUSC 164T extract (mg/mL)Mean ± standard deviation (%)
DPPH0.125ND
0.25ND
0.52.42 ± 1.58*
1.06.66 ± 1.91*
2.018.31 ± 2.03*
ABTS0.1255.14 ± 0.94*
0.258.27 ± 1.63*
0.510.63 ± 0.54*
1.018.14 ± 1.72*
2.030.38 ± 2.27*
Superoxide dismutase-like0.0937553.09 ± 2.53*
0.187556.92 ± 1.71*
0.37569.46 ± 0.64*
0.7569.94 ± 1.51*
1.579.84 ± 1.16*
Metal-chelating0.125NA
0.2514.41 ± 2.08*
0.520.48 ± 1.58*
1.029.29 ± 0.66*
2.043.66 ± 0.98*

Radical scavenging activity of MUSC 164T evaluated using different antioxidant assays.

Symbol (*) indicates p < 0.05 significant difference between MUSC 164T extract and controls (without MUSC 164T extract).

*

NA, not available, ND, not detected.

As antioxidant assays revealed presence of antioxidant(s) in MUSC 164T extract, in vitro cellular screening assay was then performed. The aim of this screening is to investigate if the extract is capable of protecting neuronal cells against the oxidative stress cellular damage elicited by an oxidative stress inducer, H2O2. Even though with short half-life, H2O2 is highly soluble in water and dissociates to hydroxyl and superoxide ions, which leads to oxidative damage to important macromolecules and ultimately cell death (Triana-Vidal and Carvajal-Varona, 2013). Thus, this molecule has been used widely in oxidative studies (Whittemore et al., 1995; Suematsu et al., 2011; Wong et al., 2012; Triana-Vidal and Carvajal-Varona, 2013). Initially, the viability of SH-SY5Y cells was examined following exposure to the extract up to 400 μg/mL and no significant toxic effect was observed in SH-SY5Y (i.e., cell viability remains >98%). In subsequent neuroprotective experiment, the obtained results have demonstrated MUSC 164T extract confers a significant level of protection on neuronal cells when challenged with H2O2. Highest cell viability was recorded at 80.62 ± 2.75% when neuronal cells were pre-treated with 400 μg/mL of extract (Figure 3) prior to induction by H2O2. As antioxidant assays suggested presence of antioxidant(s) in the extract, these compounds can possibly quench H2O2, preventing oxidative damage against the neuronal cells. Previous study has showed that compounds produced by Streptomyces sp. protect primary cortical neurons against oxidative stress, accompanied by alteration in the expression of apoptotic genes and transcription factor for antioxidant pathways (Leiros et al., 2013). Thus, further study on underlying neuroprotective mechanisms induced by MUSC 164T would be helpful for the development of new drugs in preventing the occurrence of neurodegenerative disorders.

Figure 3

Following the evaluation of bioactivities possessed by MUSC 164T extract, GC-MS was performed to assist with the chemical profiling and to identify compounds present in the extract. This technique enables identification of compounds present in Streptomyces extract as GC separates the compounds and MS generates characteristic mass profile for each of the compounds present (Pollak and Berger, 1996; Karanja et al., 2010; Jog et al., 2014). Our results revealed 24 compounds present in MUSC 164T extract (Table 4) and their chemical structures (Figure 4, Figure S4) as Pyrazine, 2,5-dimethyl- (1), Pyrazine, 2,3-dimethyl- (2), Dimethyl trisulfide (3), Pyrazine, 2-ethyl-5-methyl- (4), Pyrazine, trimethyl- (5), Pyrazine, 3-ethyl-2,5-dimethyl- (6), 4-Pyridinamine, N,N,2-trimethyl- (7), 2,3-Dimethyl-5-ethylpyrazine (8), Benzoic acid, methyl ester (9), Pyrazine, 2-methyl-5-(1-propenyl)-, (E)- (10), Pyrazine, 3,5-diethyl-2-methyl- (11), 2-Piperidinone (12), Pyrazine, 2,5-dimethyl-3-(2-methylpropyl)- (13), Indolizine (14), Pyrazine, 2,5-dimethyl-3-(3-methylbutyl)- (15), Pyrazine, 3,5-dimethyl-2-propyl- (16), 2,3,5-Trimethyl-6-ethylpyrazine (17), Phenol, 2,4-bis(1,1-dimethylethyl)- (18), 1,2,3,4-Tetrahydro-cyclopenta[b]indole (19), Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro- (20), Phenol, 3,5-dimethoxy- (21), Hexadecanoic acid, methyl ester (22), Pentadecanoic acid, 14-methyl, methyl ester (23) and Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(2-phenylmethyl)- (24).

Table 4

NoRetention time (min)CompoundFormulaMolecular weight (MW)Quality (%)
113.484Pyrazine, 2,5-dimethyl-C6H8N2108.1490
214.022Pyrazine, 2,3-dimethyl-C6H8N2108.1480
317.111Dimethyl trisulfideC2H6S3126.2678
419.526Pyrazine, 2-ethyl-5-methyl-C7H10N2122.1790
519.595Pyrazine, trimethyl-C7H10N2122.1778
624.218Pyrazine, 3-ethyl-2,5-dimethyl-C8H12N2136.1994
724.5444-Pyridinamine, N,N,2-trimethyl-C8H12N2136.1953
824.6302,3-Dimethyl-5-ethylpyrazineC8H12N2136.1991
924.985Benzoic acid, methyl esterC8H8O2136.1590
1025.265Pyrazine, 2-methyl-5-(1-propenyl)-, (E)-C8H10N2134.1859
1128.464Pyrazine, 3,5-diethyl-2-methyl-C9H14N2150.2272
1229.5402-PiperidinoneC5H9NO99.1359
1330.701Pyrazine, 2,5-dimethyl-3-(2-methylpropyl)-C10H16N2164.2580
1434.970IndolizineC8H7N117.1564
1536.057Pyrazine, 2,5-dimethyl-3-(3-methylbutyl)-C11H18N2178.2783
1637.024Pyrazine, 3,5-dimethyl-2-propyl-C9H14N2150.2264
1744.1422,3,5-Trimethyl-6-ethylpyrazineC9H14N2150.2268
1844.474Phenol, 2,4-bis(1,1-dimethylethyl)-C14H22O206.3295
1946.9691,2,3,4-Tetrahydro-cyclopenta[b]indoleC11H11N157.2187
2053.251Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-C7H10N2O2154.1797
2156.158Phenol, 3,5-dimethoxy-C8H10O3154.1658
2258.041Hexadecanoic acid, methyl esterC17H34O2270.4594
2359.242Pentadecanoic acid, 14-methyl, methyl esterC17H34O2270.4590
2472.065Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(2-phenylmethyl)-C14H16N2O2244.2997

Compounds identified from MUSC 164T extract using GC-MS.

Figure 4

Through GC-MS, most of the compounds were identified to be heterocyclic organic compounds. Naturally occurring phenolic compounds have been widely accepted as potent antioxidants and these compounds are believed to play an important role in the prevention of chronic diseases resulting from oxidative stress (Soobrattee et al., 2005; Gülcin and Beydemir, 2013). The phenolic compound 18 has been detected in previously isolated Streptomyces sp. from vermicompost and mangrove forest (Narendhran et al., 2014; Tan et al., 2015; Ser et al., 2015a,c). This compound has been shown to exhibit antioxidant activity, probably owing to its hydrogen-donating ability (Brewer, 2011; Narendhran et al., 2014). On the other hand, pyrazines are heterocyclic compounds that contain two nitrogen atoms in their aromatic ring; some of these compounds are known to exhibit various bioactivities including antimicrobial, anticancer, antioxidant, neuroprotection against ischemia/reperfusion injuries and hypoxia (Premkumar and Govindarajan, 2005; Jia et al., 2009; Baldwin et al., 2013; Tan et al., 2015; Ser et al., 2015a,c). Previous studies have demonstrated that microorganisms are capable of producing compounds 1, 2, 5, 6, 15, and 17 with antioxidant activity (Sun et al., 2013; Citron et al., 2015; Pongsetkul et al., 2015). Bacillus methylotrophicus KOSM11 was used in fermentation industry for traditional soybean paste and found to produce compound 1 and 5; the presence of these pyrazines and their related compounds in various food and plants have been linked with antioxidant activities (Liu et al., 2012; Sun et al., 2013; Xu et al., 2015). Furthermore, two pyrrolopyrazines were observed in MUSC 164T extract, which are compound 20 and 24. These compounds were previously detected in several Streptomyces sp. and they have been associated with antioxidant activity exhibited by these strains (Gopi et al., 2014; Tan et al., 2015; Ser et al., 2015a,c). Gopi et al. (2014) has also reported that these compounds were highly capable of scavenging or reducing amount of free radicals when assessed with reducing power assay. Thus, the detection of these heterocyclic compounds present in MUSC 164T could account for the antioxidant activity and protect SH-SY5Y cells against H2O2 insults.

The current study described a novel streptomycete designated as MUSC 164T that produces a mixture of compounds, with some of them could be responsible for the free radical scavenging activities detected via several antioxidant assays. Furthermore, the extract has demonstrated its potential in conferring neuroprotection against oxidative insults, possibly by preventing oxidative stress and activating of antioxidant defense systems that are crucial for survival of SH-SY5Y cells. In conclusion, these preliminary studies have revealed the antioxidative and in vitro neuroprotective properties of MUSC 164T which merit for further investigations focusing on the isolation and characterization of chemical compounds using bioassay-guided purification. The identified bioactive principles could essentially be important for the development of pharmacological agents for neurodegenerative diseases.

Description of Streptomyces antioxidans sp. nov.

Streptomyces antioxidans sp. nov. (an.ti.o′xi.dans. Gr. pref. anti, against; N.L. v. oxidare, to oxidize; N.L. part. adj. antioxidans, non-oxidizing, referring to the antioxidant properties of this strain).

Gram-positive actinobacteria that forms yellowish-white aerial and brilliant greenish yellow substrate mycelium on ISP 2 agar. The colors of the aerial and substrate mycelium are media-dependent (Table S1).

Abundant growth was observed on ISP 2, ISP 3, ISP 5, ISP 6, ISP 7, actinomycetes isolation agar, starch casein agar and nutrient agar after 7–14 days at 28°C; cells grow moderately on Streptomyces agar, and does not grow on ISP 4 agar. Cells grow at 26–36°C (optimum 28–32°C), pH 6.0–8.0 (optimum pH 7.0), with 0–6% NaCl tolerance (optimum 0–2%). Cells are positive for catalase but negative for hemolytic activity and melanoid pigment production. Soluble starch and carboxymethylcellulose are hydrolyzed but casein, chitin, xylan, and tributyrin (lipase) are not. The following compounds are utilized as sole carbon sources: acetic acid, acetoacetic acid, α-D-glucose, α-hydroxy-butyric acid, α-keto-butyric acid, α-keto-glutaric acid, β-hydroxyl-D,L-butyric acid, bromo-succinic acid, D-cellobiose, D-fructose-6-phosphate, D-galactose, D-galacturonic acid, D-glucuronic acid, D-lactic acid methyl ester, D-malic acid, D-raffinose, D-saccharic acid, D-trehalose, D-turanose, formic acid, gelatin, glucuronamide, L-galactonic acid lactone, L-lactic acid, L-rhamnose, N-acetyl-D-glucosamine, N-acetyl-neuraminic acid, pectin, p-hydroxyl-phenylacetic acid, quinic acid, stachyose, sucrose, Tween 40, γ-amino-butyric acid, and myo-inositol. The following compounds are not utilized as sole carbon sources: α-D-lactose, β-methyl-D-glucoside, citric acid, D-arabitol, D-aspartic acid, Dextrin, D-fructose, D-fucose, D-glucose-6-phosphate, D-gluconic acid, D-maltose, D-mannitol, D-mannose, D-melibiose, D-salicin, D-serine, D-sorbitol, gentiobiose, glycerol, glycyl-L-proline, inosine, L-fucose, L-malic acid, methyl pyruvate, mucic acid, N-acetyl-β-D-mannosamine, N-acetyl-D-galactosamine, propionic acid, and 3-methyl glucose. The following compounds are not utilized as sole carbon sources: L-alanine, L-arginine, L-aspartic acid, L-histidine, L-pyroglutamic acid; while L-glutamic acid and L-serine are utilized as sole nitrogen sources.

The cell wall peptidoglycan contains LL-diaminopimelic acid. The predominant menaquinones are MK-9(H6) and MK-9(H8). The polar lipids consist of aminolipid, diphosphatidylglycerol, glycolipid, hydroxyphosphatidylet hanolamine, phospholipid, phosphatidylinositol, phosphatidylethanolamine, phosphatidylglycerol, and lipid. The cell wall sugars are galactose, glucose and ribose. The major cellular fatty acids are iso-C15:0 and anteiso-C15:0.

The type strain, MUSC 164T (=DSM 101523T = MCCC 1K01590T) was isolated from mangrove soil collected from the Tanjung Lumpur mangrove forest (state of Pahang, Peninsular Malaysia). The 16S rRNA gene sequence of strain MUSC 164T has been deposited in GenBank/EMBL/DDBJ under the accession number KJ632665. The G + C content of the genomic DNA of the type strain is 71.6 mol%.

Statements

Author contributions

The experiments, data analysis and manuscript writing were performed by H-LS, LT-HT, B-HG, and L-HL, UDP, SNAM, W-FY, and K-GC provided vital guidance and technical support. L-HL and B-HG founded the research project.

Acknowledgments

This work was supported by PVC Award Grant (Project Q7 No. PVC-ECR-2016), External Industry Grant (Biotek Abadi Vote No. GBA-808813), Fundamental Research Grant Scheme (FRGS/1/2013/SKK01/MUSM/03/3), MOSTI eScience funds (Project No. 06-02-10-SF0300) awarded to L-HL and MOSTI eScience funds (Project No. 02-02-10-SF0215) awarded to B-HG, and a University of Malaya for High Impact Research Grant (UM-MOHE HIR Nature Microbiome Grant No. H- 50001-A000027 and No. A000001-50001) awarded to K-GC. The authors are thankful to Professor Bernhard Schink for the support in the Latin etymology of the new species name.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supplementary material

The Supplementary Material for this article can be found online at: http://journal.frontiersin.org/article/10.3389/fmicb.2016.00899

References

  • 1

    AlongiD. M. (2008). Mangrove forests: resilience, protection from tsunamis, and responses to global climate change. Estuar. Coast. Shelf Sci.76, 1–13. 10.1016/j.ecss.2007.08.024

  • 2

    AtlasR. M. (1993). Handbook of Microbiological Media, ed ParksL. C.Boca Raton, FL: CRC Press

  • 3

    AzmanA.-S.OthmanI.VeluS. S.ChanK.-G.LeeL.-H. (2015). Mangrove rare actinobacteria: taxonomy, natural compound, and discovery of bioactivity. Front. Microbiol.6:856. 10.3389/fmicb.2015.00856

  • 4

    BaldwinM. V.ArikkattS. D.SindhuT. J.ChanranM.BhatA. R.KrishnakumarK. (2013). A review of biological potential of pyrazine and related heterocyclic compounds. World J. Pharm. Pharmaceut. Sci.3, 1124–1132. Available online at: http://www.wjpps.com/wjpps_controller/abstract_id/805

  • 5

    BérdyJ. (2005). Bioactive microbial metabolites. J. Antibiot.58, 1–26. 10.1038/ja.2005.1

  • 6

    BondaD. J.WangX.PerryG.NunomuraA.TabatonM.ZhuX.et al. (2010). Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology59, 290–294. 10.1016/j.neuropharm.2010.04.005

  • 7

    BrewerM. S. (2011). Natural antioxidants: sources, compounds, mechanisms of action, and potential applications. Comp. Rev. Food Sci. Food Safety10, 221–247. 10.1111/j.1541-4337.2011.00156.x

  • 8

    CarrilloP. G.MardarazC.Pitta-AlvarezS. I.GiuliettiA. M. (1996). Isolation and selection of biosurfactant-producing bacteria. World J. Microbiol. Biotech.12, 82–84. 10.1007/BF00327807

  • 9

    CashionP.Holder-FranklinM. A.McCullyJ.FrankilnM. (1977). A rapid method for the base ratio determination of bacterial DNA. Anal. Biochem.81, 461–466. 10.1016/0003-2697(77)90720-5

  • 10

    CernyG. (1978). Studies on the aminopeptidase test for the distinction of gram-negative from gram-positive bacteria. Eur. J. Appl. Microbiol. Biotech.5, 113–122. 10.1007/BF00498805

  • 11

    ChanC. K.GohB. H.KamarudinM. N. A.KadirH. A. (2012). Aqueous fraction of Nephelium ramboutan-ake rind induces mitochondrial-mediated apoptosis in HT-29 human colorectal adenocarcinoma cells. Molecules17, 6633–6657. 10.3390/molecules17066633

  • 12

    CitronC. A.BarraL.WinkJ.DickschatJ. S. (2015). Volatiles from nineteen recently genome sequenced actinomycetes. Org. Biomol. Chem.13, 2673–2683. 10.1039/C4OB02609H

  • 13

    De LeyJ.CattoirH.ReynaertsA. (1970). The quantitative measurement of DNA hybridization from renaturation rates. Eur. J. Biochem.12, 133–142. 10.1111/j.1432-1033.1970.tb00830.x

  • 14

    DevasagayamT. P.TilakJ. C.BoloorK. K.SaneK. S.GhaskadbiS. S.LeleR. D. (2004). Free radicals and antioxidants in human health: current status and future prospects. J. Assoc. Physicians India52, 794–804.

  • 15

    FelsensteinJ. (1981). Evolutionary trees from DNA sequences: a maximum likelihood approach. J. Mol. Evol.17, 368–376. 10.1007/BF01734359

  • 16

    FelsensteinJ. (1985). Confidence limits on phylogenies: an approach using the bootstrap. Evolution39, 783–789. 10.2307/2408678

  • 17

    FischerR.MaierO. (2015). Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF. Ox. Med. Cell. longevity2015:610813. 10.1155/2015/610813

  • 18

    GopiM.DhayanithiN. B.DeviK. N.KumarT. T. A. (2014). Marine natural product, Pyrrolo [1,2-a] pyrazine-1,4-dione, hexahydro-(C7H10N2O2) of antioxidant properties from Bacillus species at Lakshadweep archipelago. J. Coast. Life Med.2, 632–637. 10.12980/JCLM.2.201414J40

  • 19

    GülcinI.BeydemirS. (2013). Phenolic compounds as antioxidants: carbonic anhydrase isoenzymes inhibitors. Mini Rev. Med. Chem.13, 408–430. 10.2174/1389557511313030009

  • 20

    HarveyA. (2000). Strategies for discovering drugs from previously unexplored natural products. Drug Dis. Today5, 294–300. 10.1016/S1359-6446(00)01511-7

  • 21

    HongK.GaoA.-H.XieQ.-Y.GaoH. G.ZhuangL.LinH.-P.et al. (2009). Actinomycetes for marine drug discovery isolated from mangrove soils and plants in China. Mar. Drugs7, 24–44. 10.3390/md7010024

  • 22

    HuH.LinH.-P.XieQ.LiL.XieX.-Q.HongK. (2012). Streptomyces qinglanensis sp. nov., isolated from mangrove sediment. Int. J. Syst. Evol. Microbiol.62, 596–600. 10.1099/ijs.0.032201-0

  • 23

    HussV. A. R.FestlH.SchleiferK. H. (1983). Studies on the spectrophotometric determination of DNA hybridization from renaturation rates. Syst. Appl. Microbiol.4, 184–192. 10.1016/S0723-2020(83)80048-4

  • 24

    JensenP. R.MincerT. J.WilliamsP. G.FenicalW. (2005). Marine actinomycete diversity and natural product discovery. Antonie van Leeuwenhoek87, 43–48. 10.1007/s10482-004-6540-1

  • 25

    JiaJ.ZhangX.HuY. S.WuY.WangQ. Z.LiN. N.et al. (2009). Protective effect of tetraethyl pyrazine against focal cerebral ischemia/reperfusion injury in rats: therapeutic time window and its mechanism. Throm. Res.123, 727–730. 10.1016/j.thromres.2008.11.004

  • 26

    JogR.PandyaM.NareshkumarG.RajkumarS. (2014). Mechanism of phosphate solubilization and antifungal activity of Streptomyces spp. isolated from wheat roots and rhizosphere and their application in improving plant growth. Microbiology160, 778–788. 10.1099/mic.0.074146-0

  • 27

    KaranjaE.BogaH.MuigaiA.WamunyokoliF.KinyuaJ.NonohJ. (2010). Growth Characteristics and production of secondary metabolites from selected novel Streptomyces species isolated from selected Kenyan national parks. Sci. Conf. Proc.51–80. Available online at: http://journals.jkuat.ac.ke/index.php/jscp/article/view/672

  • 28

    KatesM. (1986). Lipid Extraction Procedures. Techniques of Lipidology.Amsterdam: Elsevier.

  • 29

    KellyK. L. (1964). Inter-Society Color Council–National Bureau of Standards Color Name Charts Illustrated with Centroid Colors.Washington, DC: US Government Printing Office

  • 30

    KimS. B.LonsdaleJ.SeongC. N.GoodfellowM. (2003). Streptacidiphilus gen. nov., acidophilic actinomycetes with wall chemotype I and emendation of the family Streptomycetaceae (Waksman and Henrici (1943)AL) emend. Rainey et al. 1997. Antonie van Leeuwenhoek83, 107–116. 10.1023/A:1023397724023

  • 31

    KimO. S.ChoY. J.LeeK.YoonS. H.KimM.NaH.ParkS. C.et al. (2012). Introducing EzTaxon-e: a prokaryotic 16S rRNA gene sequence database with phylotypes that represent uncultured species. Int. J. Syst. Evol. Microbiol.62, 716–721. 10.1099/ijs.0.038075-0

  • 32

    KimuraM. (1980). A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol.16, 111–120. 10.1007/BF01731581

  • 33

    KumarV.NaikB.GusainO.BishtG. S. (2014). An actinomycete isolate from solitary wasp mud nest having strong antibacterial activity and kills the Candida cells due to the shrinkage and the cytosolic loss. Front. Microbiol.5:446. 10.3389/fmicb.2014.00446

  • 34

    KüsterE.WilliamsS. (1964). Media for the isolation of streptomycetes: starch casein medium. Nature202, 928–929. 10.1038/202928a0

  • 35

    LassmannH.van HorssenJ. (2015). Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions. BBA Mol. Basis Dis. 1862, 506–510. 10.1016/j.bbadis.2015.09.018

  • 36

    LechevalierM. P.LechevalierH. (1970). Chemical composition as a criterion in the classification of aerobic actinomycetes. Int. J. Syst. Evol. Microbiol.20, 435–443. 10.1099/00207713-20-4-435

  • 37

    LeeJ. Y.LeeJ. Y.JungH. W.HwangB. K. (2005). Streptomyces koyangensis sp. nov., a novel actinomycete that produces 4-phenyl-3-butenoic acid. Int. J. Syst. Evol. Microbiol.55, 257–262. 10.1099/ijs.0.63168-0

  • 38

    LeeL.-H.AzmanA.-S.ZainalN.EngS.-K.Ab MutalibN.-S.YinW.-F.et al. (2014d). Microbacterium mangrovi sp. nov., an amylotytic actinobacterium isolated from mangrove forest soil. Int. J. Syst. Evol. Microbiol.64, 3513–3519. 10.1099/ijs.0.062414-0

  • 39

    LeeL. H.AzmanA. S.ZainalN.EngS. K.FangC. M.HongK.et al. (2014c). Novosphingobium malaysiense sp. nov. isolated from mangrove sediment. Int. J. Syst. Evol. Microbiol.64, 1194–1201. 10.1099/ijs.0.059014-0

  • 40

    LeeL.-H.CheahY.-K.SidikS. M.Ab MutalibN.-S.TangY.-L.LinH.-P.et al. (2012). Molecular characterization of Antarctic actinobacteria and screening for antimicrobial metabolite production. World J. Microbiol. Biotech.28, 2125–2137. 10.1007/s11274-012-1018-1

  • 41

    LeeL.-H.ZainalN.AzmanA.-S.Ab MutalibN.-S.HongK.ChanK.-G. (2014e). Mumia flava gen. nov., sp. nov., an actinobacterium of the family Nocardioidaceae. Int. J. Syst. Evol. Microbiol.64, 1461–1467. 10.1099/ijs.0.058701-0

  • 42

    LeeL.-H.ZainalN.AzmanA.-S.EngS.-K.Ab MutalibN.-S.YinW.-F.et al. (2014b). Streptomyces pluripotens sp. nov., a bacteriocin-producing streptomycete that inhibits meticillin-resistant Staphylococcus aureus. Int. J. Syst. Evol. Microbiol.64, 3297–3306. 10.1099/ijs.0.065045-0

  • 43

    LeeL. H.ZainalN.AzmanA. S.EngS. K.GohB. H.YinW. F.et al. (2014a). Diversity and antimicrobial activities of actinobacteria isolated from tropical mangrove sediments in Malaysia. Sci. World J.2014:698178. 10.1155/2014/698178

  • 44

    LeirosM.AlonsoE.SanchezJ. A.RatebM. E.EbelR.HoussenW. E.et al. (2013). Mitigation of ROS insults by Streptomyces secondary metabolites in primary cortical neurons. ACS Chem. Neurosci.5, 71–80. 10.1021/cn4001878

  • 45

    LeszekJ. E.BarretoG. E.GasiorowskiK.KoutsourakiE.AlievG. (2016). Inflammatory mechanisms and oxidative stress as key factors responsible for progression of neurodegeneration: role of brain innate immune system. CNS Neurol. Dis. Drug Targets15, 329–336. 10.2174/1871527315666160202125914

  • 46

    LinM. T.BealM. F. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature443, 787–795. 10.1038/nature05292

  • 47

    LiuP.HuangM.SongS.HayatK.ZhangX.XiaS.et al. (2012). Sensory characteristics and antioxidant activities of Maillard reaction products from soy protein hydrolysates with different molecular weight distribution. Food Bioproc. Tech.5, 1775–1789. 10.1007/s11947-010-0440-3

  • 48

    MacfaddinJ. (2000). Biochemical Tests for Identification of Medical Bacteria. Philadelphia, PA: Lippincott Williams and Wilkins.

  • 49

    ManivasaganP.VenkatesanJ.SivakumarK.KimS. K. (2013). Production, characterization and antioxidant potential of protease from Streptomyces sp. MAB18 using poultry wastes. BioMed. Res. Int.2013:496586. 10.1155/2013/496586

  • 50

    MeenaB.RajanL. A.VinithkumarN. V.KirubagaranR. (2013). Novel marine actinobacteria from emerald Andaman & Nicobar Islands: a prospective source for industrial and pharmaceutical byproducts. BMC Microbiol.13:145. 10.1186/1471-2180-13-145

  • 51

    MesbahM.PremachandranU.WhitmanW. B. (1989). Precise measurement of the G+ C content of deoxyribonucleic acid by high-performance liquid chromatography. Int. J. Syst. Bacteriol.39, 159–167. 10.1099/00207713-39-2-159

  • 52

    Miser-SalihogluE.AkaydinG.Caliskan-CanE.Yardim-AkaydinS. (2013). Evalution of antioxidant activity of various herbal folk medicines. J. Nutri. Food Sci.3:222. 10.4172/2155-9600.1000222

  • 53

    NarendhranS.RajivP.VanathiP.SivarajR. (2014). Spectroscopic analysis of bioactive compounds from Streptomyces cavouresis KU-V39: evaluation of antioxidant and cytotoxicity activity. Int. J. Pharm. Pharmaceut. Sci.6, 319–322. Available online at: http://innovareacademics.in/journals/index.php/ijpps/article/view/2009

  • 54

    PenesyanA.KjellebergS.EganS. (2010). Development of novel drugs from marine surface associated microorganisms. Mar. Drugs8, 438–459. 10.3390/md8030438

  • 55

    PollakF. C.BergerR. G. (1996). Geosmin and related volatiles in bioreactor-cultured Streptomyces citreus CBS 109.60. Appl. Environ. Microbiol.62, 1295–1299.

  • 56

    PongsetkulJ.BenjakulS.SampavapolP.OsakoK.FaithongN. (2015). Chemical compositions, sensory and antioxidative properties of salted shrimp paste (Ka-pi) in Thailand. Int. Food Res. J.22, 155–166. 10.1007/s40071-014-0076-4

  • 57

    PremkumarT.GovindarajanS. (2005). Antimicrobial study of pyrazine, pyrazole and imidazole carboxylic acids and their hydrazinium salts. World J. Microbiol. Biotech.21, 479–480. 10.1007/s11274-004-2041-7

  • 58

    RadiE.FormichiP.BattistiC.FedericoA. (2014). Apoptosis and oxidative stress in neurodegenerative diseases. JAD42, S125–S152. 10.3233/JAD-132738

  • 59

    SaitouN.NeiM. (1987). The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol.4, 406–425.

  • 60

    SasserM. (1990). Identification of Bacteria by Gas Chromatography of Cellular Fatty Acids.Newark, DE: DEMIDI Inc. MIDI Technical Note 101.

  • 61

    SchumannP. (2011). 5- Peptidoglycan structure. Met. Microbiol.38, 101–129. 10.1016/b978-0-12-387730-7.00005-x

  • 62

    SerH.-L.PalanisamyU. D.YinW.-F.Abd MalekS. N.ChanK.-G.GohB.-H.et al. (2015a). Presence of antioxidative agent, Pyrrolo[1,2-a]pyrazine-1,4-dione,hexahydro- in newly isolated Streptomyces mangrovisoli sp. nov. Front. Microbiol.6:854. 10.3389/fmicb.2015.00854

  • 63

    SerH.-L.ZainalN.PalanisamyU. D.GohB.-H.YinW.-F.ChanK.-G.et al. (2015b). Streptomyces gilvigriseus sp. nov., a novel actinobacterium isolated from mangrove forest soil. Antonie van Leeuwenhoek107, 1369–1378. 10.1007/s10482-015-0431-5

  • 64

    SerH.-L.Ab MutalibN.-S.YinW.-F.ChanK.-G.GohB. H.LeeL. H. (2015c). Evaluation of antioxidative and cytotoxic activities of Streptomyces pluripotens MUSC 137 isolated from mangrove soil in Malaysia. Front. Microbiol.6:1398. 10.3389/fmicb.2015.01398

  • 65

    SerH.-L.LawJ. W.-F.ChaiyakunaprukN.JacobS. A.PalanisamyU. D.ChanK.-G.et al. (2016a). Fermentation conditions that affect clavulanic acid production in Streptomyces clavuligerus: a systematic review. Front. Microbiol.7:522. 10.3389/fmicb.2016.00522

  • 66

    SerH.-L.PalanisamyU. D.YinW.-F.ChanK.-G.GohB.-H.LeeL.-H. (2016b). Streptomyces malaysiense sp. nov.: a novel Malaysian mangrove soil actinobacterium with antioxidative activity and cytotoxic potential against human cancer cell lines. Sci. Rep.6:24247. 10.1038/srep24247

  • 67

    ShirlingE. B.GottliebD. (1966). Methods for characterization of Streptomyces species. Int. J. Syst. Evol. Microbiol.16, 313–340. 10.1099/00207713-16-3-313

  • 68

    SoobratteeM. A.NeergheenV. S.Luximon-RammaA.AruomaO. I.BahorunT. (2005). Phenolics as potential antioxidant therapeutic agents: mechanism and actions. Mut. Res./Fund. Mol. Mech. Mutagen.579, 200–213. 10.1016/j.mrfmmm.2005.03.023

  • 69

    StaneckJ. L.RobertsG. D. (1974). Simplified approach to identification of aerobic actinomycetes by thin-layer chromatography. Appl. Microbiol.28, 226–231.

  • 70

    SuematsuN.HosodaM.FujimoriK. (2011). Protective effects of quercetin against hydrogen peroxide-induced apoptosis in human neuronal SH-SY5Y cells. Neurosci. Lett.504, 223–227. 10.1016/j.neulet.2011.09.028

  • 71

    SuiJ.-L.XuX.-X.QuZ.WangH.-L.LinH.-P.XieQ.-Y.et al. (2011). Streptomyces sanyensis sp. nov., isolated from mangrove sediment. Int. J. Syst. Evol. Microbiol.61, 1632–1637. 10.1099/ijs.0.023515-0

  • 72

    SunX.-S.LiW.-H.LiR.GaoC.-Q.CuiG.-Y. (2013). Antioxidative activity of sulfide and pyrazine compositions in sesame-flavor liquor. Liquor Making40, 57–60.

  • 73

    SupriadyH.KamarudinM. N. A.ChanC. K.GohB. H.KadirH. A. (2015). SMEAF attenuates the production of pro-inflammatory mediators through the inactivation of Akt-dependent NF-κB, p38 and ERK1/2 pathways in LPS-stimulated BV-2 microglial cells. J. Func. Foods17, 434–448. 10.1016/j.jff.2015.05.042

  • 74

    TakahashiY.MatsumotoA.SeinoA.IwaiY.OmuraS. (1996). Rare actinomycetes isolated from desert soils. Actinomycetologica10, 91–97. 10.3209/saj.10_91

  • 75

    TamuraK.StecherG.PetersonD.FilipskiA.KumarS. (2013). MEGA6: molecular evolutionary genetics analysis version 6.0. Mol. Biol. Evol.30, 2725–2729. 10.1093/molbev/mst197

  • 76

    TanL. T. H.ChanK. G.LeeL. H.GohB. H. (2016). Streptomyces bacteria as potential probiotics in aquaculture. Front. Microbiol.7:79. 10.3389/fmicb.2016.00079

  • 77

    TanL. T. H.SerH. L.YinW. F.ChanK. G.LeeL. H.GohB. H. (2015). Investigation of antioxidative and anticancer potentials of Streptomyces sp. MUM256 isolated from Malaysia mangrove soil. Front. Microbiol.6:1316. 10.3389/fmicb.2015.01316

  • 78

    ThompsonJ. D.GibsonT. J.PlewniakF.JeanmouginF.HigginsD. G. (1997). The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res.25, 4876–4882. 10.1093/nar/25.24.4876

  • 79

    Triana-VidalL. E.Carvajal-VaronaS. M. (2013). Protective effect of galantamine against oxidative damage using human lymphocytes: a novel in vitro model. Arch. Med. Res.44, 85–92. 10.1016/j.arcmed.2013.01.001

  • 80

    UttaraB.SinghA. V.ZamboniP.MahajanR. T. (2009). Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol.7, 65. 10.2174/157015909787602823

  • 81

    VersalovicJ.KoeuthT.LupskiJ. R. (1991). Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res.19, 6823–6831. 10.1093/nar/19.24.6823

  • 82

    WaksmanS. A.HenriciA. T. (1943). The nomenclature and classification of the actinomycetes. J. Bacteriol.46, 337–341.

  • 83

    WangC.WangZ.QiaoX.LiZ.LiF.ChenM.et al. (2013). Antifungal activity of volatile organic compounds from Streptomyces alboflavus TD-1. FEMS Microbiol. Lett.341, 45–51. 10.1111/1574-6968.12088

  • 84

    WayneL. G.BrennerD. J.ColwellR. R.GrimontP. A. D.KandlerO.KrichevskyM. I.et al. (1987). Report of the ad hoc committee on reconciliation of approaches to bacterial systematics. Int. J. Syst. Bacteriol.37, 463–464. 10.1099/00207713-37-4-463

  • 85

    WhitonR. S.LauP.MorganS. L.GilbartJ.FoxA. (1985). Modifications in the alditol acetate method for analysis of muramic acid and other neutral and amino sugars by capillary gas chromatography-mass spectrometry with selected ion monitoring. J. Chromato. A347, 109–120. 10.1016/S0021-9673(01)95474-3

  • 86

    WhittemoreE. R.LooD. T.WattJ. A.CotmansC. W. (1995). A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture. Neuroscience67, 921–932. 10.1016/0306-4522(95)00108-U

  • 87

    WilliamsP. G. (2009). Panning for chemical gold: marine bacteria as a source of new therapeutics. Trends Biotech.27, 45–52. 10.1016/j.tibtech.2008.10.005

  • 88

    WilliamsS. T.GoodfellowM.AldersonG. (1989). Genus Streptomyces Waksman and Henrici 1943, 339AL, in: Bergey's Manual of Systematic Bacteriology, eds WilliamsS. T.SharpeM. E.HoltJ. G. (Baltimore: Williams & Wilkins), 2452–2492

  • 89

    WongD. Z. H.KadirH. A.LeeC. L.GohB. H. (2012). Neuroprotective properties of Loranthus parasiticus aqueous fraction against oxidative stress-induced damage in NG108-15 cells. J. Nat. Med.66, 544–551. 10.1007/s11418-011-0622-y

  • 90

    XuC.-P.LiuY.ZhaoS.ZengY.LiuS. (2015). Chemical composition and in vitro antioxidant activity of the essential oil of Rehmannia Glutinosa libosch using ultrasound as a pretreatment. J. Biol. Active Prod. from Nat.5, 276–282. 10.1080/22311866.2015.1073628

  • 91

    XuJ.WangY.XieS.-J.XuJ.XiaoJ.RuanJ.-S. (2009). Streptomyces xiamenensis sp. nov., isolated from mangrove sediment. Int. J. Syst. Evol. Microbiol.59, 472–476. 10.1099/ijs.0.000497-0

Summary

Keywords

Streptomyces antioxidans, actinobacteria, mangrove, neuroprotective, antioxidative

Citation

Ser H-L, Tan LT-H, Palanisamy UD, Abd Malek SN, Yin W-F, Chan K-G, Goh B-H and Lee L-H (2016) Streptomyces antioxidans sp. nov., a Novel Mangrove Soil Actinobacterium with Antioxidative and Neuroprotective Potentials. Front. Microbiol. 7:899. doi: 10.3389/fmicb.2016.00899

Received

15 March 2016

Accepted

26 May 2016

Published

16 June 2016

Volume

7 - 2016

Edited by

Yuji Morita, Aichi Gakuin University, Japan

Reviewed by

Jem Stach, University of Newcastle, UK; Huda Mahmoud Mahmoud, Kuwait University, Kuwait; Janice Lorraine Strap, University of Ontario Institute of Technology, Canada

Updates

Copyright

*Correspondence: Bey-Hing Goh ;

This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics